Robert Hamilton on The Recent Announcement from Philips and Royal London Hospital
Robert Hamilton, Chief Executive Officer of NeuraSignal, shared on LinkedIn:
”The recent announcement from Philips and Royal London Hospital represents exactly the kind of forward progress our field needs: rethinking the entire stroke pathway, not just optimizing one step of it.
What stood out to me in this work is the focus on workflow redesign.
Stroke care is a chain of time-critical decisions, and the strength of that chain depends on how well clinical teams, technology, and operational processes are aligned.
When organizations take a system-wide approach like Philips and Barts Health NHS Trust have done here, the impact reaches far beyond any single device or modality.
For those of us working in neurovascular innovation, efforts like this matter.
They signal a broader shift toward integrated, data-driven stroke care where imaging, monitoring, automation, and clinical insight work together rather than in isolation.
It’s the kind of environment where technologies like automated cerebral blood flow monitoring can meaningfully contribute and where collaboration across companies and clinical teams can raise the standard of care as a whole.
Congratulations to the teams at Philips, Barts Health, and Royal London Hospital.
Redesigning a pathway is hard work, but it’s the kind of work that changes outcomes.
Read the full story here.
Also great to see Dr Paul Bhogal and his excellent work.”

Stay updated with Hemostasis Today.
-
Apr 5, 2026, 19:00Kausik Ray: Comparing Lipid Management in France vs. Rest of Europe for High Cardiovascular Risk Patients
-
Apr 5, 2026, 18:22Omar Adwan: Systematic Approach to Blood Smear Examination
-
Apr 5, 2026, 18:05Heghine Khachatryan: Rethinking Hemostatic Targets in Pregnancy for von Willebrand Disease
-
Apr 5, 2026, 17:45Matthew Walls: Recognising CAD PRS as a New ‘Risk Enhancing Factor’ in the 2026 ACC/AHA Guidelines
-
Apr 5, 2026, 17:44Philip A. Chan: Occasional Heavy Drinking Leads to 3 Times Higher Liver Fibrosis Risk in MASLD
-
Apr 5, 2026, 17:42Josu de la Fuente: Real World Data Shows Significant Risk of Subsequent HCT in SCD and Thalassemia
-
Apr 5, 2026, 17:41Gevorg Yaghjyan: Attending an AI Conference on AI in Clinical Medicine, Research and Education
-
Apr 5, 2026, 17:41Ifeanyichukwu Ifechidere: The Mastermind of Clotting – A Thrombin Story
-
Apr 5, 2026, 17:38Thomas Ichim: Making iPSC Cells from Menstrual Blood Stem Cells